Mode
Text Size
Log in / Sign up

Comparative Efficacy of Neuromodulation Techniques for Managing Chronic Herpes Zoster PainCombination therapies may improve pain for herpes zoster patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Combination therapies like SCS+PRF offer superior pain relief, while SCS alone most effectively reduces pregabalin dosage.

This network meta-analysis provides a comprehensive evaluation of various neuromodulation techniques for patients suffering from herpes zoster-related pain. The study analyzed a large cohort of 1035 patients to compare the efficacy of spinal cord stimulation (SCS), peripheral nerve stimulation (PNS), pulsed radiofrequency (PRF), and combinations thereof. By utilizing PRF as the reference group, the analysis aimed to establish a hierarchy of treatment effectiveness for chronic neuropathic pain management.

The primary outcome measured was the reduction in pain intensity. The data indicated that combining SCS with PRF resulted in a statistically significant greater reduction in pain compared to PRF alone. This suggests that multimodal approaches involving spinal cord intervention may provide superior analgesic effects than localized radiofrequency treatments alone.

Secondary outcomes included treatment success rates and improvements in quality of life metrics. Patients receiving the combination of SCS and PRF demonstrated higher success rates compared to those receiving only PRF. Furthermore, the integration of PNS with PRF showed significant improvements in sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI), highlighting the importance of addressing comorbid sleep disturbances in zoster patients.

A critical finding for clinical practice involves the reduction of systemic pharmacological intervention. Patients treated with SCS alone demonstrated the greatest reduction in pregabalin dosage, suggesting that spinal cord stimulation can effectively replace a portion of the daily medication burden. This is particularly relevant for patients who experience side effects from long-term anticonvulsant use.

Functional outcomes were also assessed using the SF-36 survey. Patients receiving SCS alone showed significant improvements in both the physical role and bodily pain domains compared to the reference group. These results suggest that SCS not only mitigates raw pain intensity but also improves the patient's ability to perform daily activities and manage physical limitations.

While several interventions showed marked benefits, it is important to note that no statistically significant differences were observed among the various modalities regarding the SF-36 physical function domain. This indicates that while pain perception and role performance improved with SCS, the specific metric of physical function remained consistent across groups. Clinicians should consider these findings when tailoring neuromodulation plans based on specific patient goals.

In conclusion, combination therapies like SCS plus PRF offer superior pain reduction compared to monotherapy. Additionally, PNS combined with PRF is effective for improving sleep quality, while standalone SCS provides the most significant reduction in pregabalin requirements and improvements in bodily pain scores. These findings support a tailored approach to neuromodulation based on whether the primary goal is pain reduction, medication tapering, or improved sleep.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in managing herpes zoster-related pain by evaluating advanced neuromodulation. It complements previous findings where pregabalin 300 or 600 mg/day was shown to reduce pain in diabetic peripheral neuropathy, and it provides an alternative for patients who may need to reduce gabapentinoid use, which has been associated with risks in other populations.

People who experience herpes zoster, commonly known as shingles, often deal with lingering and intense nerve pain after the initial rash fades. This chronic pain can be difficult to manage and significantly impacts a person's ability to sleep, work, and enjoy daily activities. Because of these challenges, finding effective ways to manage long-term discomfort is a major focus for medical researchers.

A large review analyzed data from over 1,000 patients to compare different types of nerve stimulation treatments. These methods include spinal cord stimulation (SCS), peripheral nerve stimulation (PNS), and pulsed radiofrequency (PRF). The study looked at how these treatments performed individually and when they were combined to see which methods provided the best relief for shingles-related pain.

The results showed that combining certain techniques could be more effective than using them alone. Specifically, patients who received both spinal cord stimulation and pulsed radiofrequency reported a greater reduction in pain intensity and a higher success rate compared to those receiving only pulsed radiofrequency. Additionally, combining peripheral nerve stimulation with pulsed radiofrequency led to better improvements in sleep quality for the patients involved.

Another finding showed that spinal cord stimulation alone was particularly effective at reducing the amount of medication needed. Patients receiving this treatment were able to lower their daily dose of pregabalin, a common medication used to treat nerve pain. This group also reported better scores on physical role and bodily pain scales, suggesting they felt more capable in their daily lives despite the condition.

It is important to note that while these results are promising, this was a network meta-analysis, which means it looks at data from many different studies rather than one single trial. The study did not find significant differences between the various treatments when it came to improving general physical function scores. Furthermore, there were no specific reports on safety concerns or side effects for these procedures in this particular analysis.

For patients today, this research suggests that combination therapies might offer a more robust way to manage shingles pain than single-method approaches. However, because every patient's body and nerve damage are different, these findings do not mean one specific treatment is a guaranteed cure. Patients should talk with their doctors about which neuromodulation options best fit their specific symptoms and goals.

What this means for you:
Combining different nerve stimulation methods may offer better pain relief and lower medication needs for shingles.

Study Details

Study typeSystematic review
Sample sizen = 1,035
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: Neuromodulation therapy is gaining importance in managing chronic neuropathic pain. This network meta-analysis aims to compare the efficacy and safety of spinal cord stimulation (SCS), peripheral nerve stimulation (PNS), pulsed radiofrequency (PRF), and their combinations in the management of herpes zoster (HZ)-related pain. METHODS: We searched Scopus, Cochrane CENTRAL, PubMed, and Web of Science from inception until August 27, 2025. Clinical trials and observational studies evaluating the efficacy and safety of SCS, PNS, PRF, or their combinations in HZ-related pain were included. Mean difference (MD) and risk ratio (RR) with corresponding 95% confidence intervals (CIs) were pooled. RESULTS: Eleven studies (1035 patients) were included. When compared to the reference group (PRF), SCS+PRF achieved the greatest reduction in pain intensity (MD: -3.58 points, 95% CI: -5.05 to -2.12) and the highest treatment success rate (RR: 2.54, 95% CI;: 1.45 to 4.45). PNS+PRF demonstrated the most significant improvement in Pittsburgh Sleep Quality Index (PSQI) score (MD: -1.75 points, 95% CI: -3.24 to -0.27), while SCS alone showed the greatest reduction in pregabalin dose (MD: -36.58 mg, 95% CI: -68.93 to -4.24), physical role (MD: 9.70 points, 95% CI: 6.21 to 13.19), and bodily pain (MD: 8.42 points, 95% CI: 2.10 to 14.73) domains of the Short Form-36 (SF-36) score, while no significant differences were observed among the interventions regarding the physical function domain. CONCLUSION: Combination neuromodulation therapies, particularly SCS+PRF, may provide superior pain relief. PNS+PRF and PNS also showed marked improvements in sleep quality, whereas SCS was most effective in reducing pregabalin use and enhancing SF-36 scores.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.